Atlas Trials

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial

Clinical trial NCT04483960 · UNKNOWN

Trial details

NCT number
NCT04483960
Sponsor
University of Melbourne
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
SARS-CoV-2 Infection (COVID-19)
Start date
2020-07-28
Primary completion
2025-07-25
Enrollment
2200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.